Merck partners with HiberCell for Phase Ib renal carcinoma trial

2 years ago 58

The Phase Ib trial will evaluate the combination therapy of Welireg and HC-7366 in patients with clear cell renal cell carcinoma.

1. Homepage
2. category-label-
3. Merck partners with HiberCell for Phase Ib renal carcinoma trial